GRI

Anvisa approves 7th edition of the Brazilian Pharmacopoeia

News Healthcare & Pharma Reports
Date: 14th Nov, 2024 Source: National Health Surveillance Agency (Anvisa) Country: Brazil Original Source

Brief

"On November 13, 2024, the National Health Surveillance Agency (Anvisa) approved the 7th edition of the Brazilian Pharmacopoeia. This update includes 12 new items, revises 47 others, and excludes two texts, marking a significant milestone in the agency's efforts to promote scientific reference and quality control."

This content is restricted.

Highlights content goes here...

This content is restricted.

National Health Surveillance Agency (Anvisa)

Quick Insight
RADA.AI
RADA.AI
Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?
Suggested
Related Documents
Take multiple measures to strictly investigate illegal use of buses
Date: 12th Apr, 2025 Source: Central Commission for Discipline Inspection Country: China
News Anti-bribery and corruption Reports
More than 4 million workers start receiving salary allowance on Tuesday (15)
Date: 11th Apr, 2025 Source: Ministry of Labor and Employment Country: Brazil
News Employment & labor Reports
IRS has already received 11,564,854 Income Tax Declarations 2025
Date: 11th Apr, 2025 Source: Federal Revenue Service (Receita Federal) Country: Brazil
News Tax & Compliance Reports

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Click here

Enter your Email

Enter your registered username/email id.

Enter your Email

Enter your email id below to signup.
Individual Plan
  • Designed for Growing Compliance Teams
$125 / month OR $1250 / year
Features
  • • Coverage for 20 jurisdictions
  • • Monitoring from 500+ regulatory authorities
  • • AI compliance summaries
  • • RaDa.ai : Single-Role
Best for: Researchers, Legal professionals, Academics
Subscribe Now
Enterprise Plan
  • Perfect for Global Enterprises
Contact for Pricing
Features
  • • Custom jurisdictional coverage
  • • Custom monitoring of regulatory authorities
  • • RaDa.ai : Customizable multi-role
  • • Custom reporting and dashboard capabilities
  • • API access for seamless integration
Best for: Law Firms, Corporations, Government Bodies
Contact Sales